Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Operating Leases (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Operating Leases for 3 consecutive years, with $135.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases rose 4.6% year-over-year to $135.4 million, compared with a TTM value of $135.4 million through Dec 2025, up 4.6%, and an annual FY2025 reading of $135.4 million, up 4.6% over the prior year.
  • Operating Leases was $135.4 million for Q4 2025 at BrightSpring Health Services, up from $128.8 million in the prior quarter.
  • Across five years, Operating Leases topped out at $208.2 million in Q1 2024 and bottomed at $128.8 million in Q3 2025.
  • Average Operating Leases over 3 years is $162.0 million, with a median of $135.4 million recorded in 2025.
  • Peak annual rise in Operating Leases hit 4.6% in 2025, while the deepest fall reached 37.4% in 2025.
  • Year by year, Operating Leases stood at $201.7 million in 2023, then plummeted by 35.8% to $129.5 million in 2024, then rose by 4.6% to $135.4 million in 2025.
  • Business Quant data shows Operating Leases for BTSG at $135.4 million in Q4 2025, $128.8 million in Q3 2025, and $132.5 million in Q2 2025.